This is an old revision of the document!
1. A method for managing the consumption risk costs of a commodity sold by a commodity provider at a fixed price comprising the steps of:
initiating a series of transactions between said commodity provider and consumers of said commodity wherein said consumers purchase said commodity at a fixed rate based upon historical averages, said fixed rate corresponding to a risk position of said consumer;
(b) identifying market participants for said commodity having a counter-risk position to said consumers; and
(c) initiating a series of transactions between said commodity provider and said market participants at a second fixed rate such that said series of market participant transactions balances the risk position of said series of consumer transactions.
This case is an appeal from a BPAI ruling (see below) finding the claims to be nonstatutory methods under 35 U.S.C. §101. The Examiner rejected the case because the claims were directed “solely to an abstract idea and solve[…] a purely mathematical problem without practical application in the technological arts.” The BPAI disagreed with the Examiner's reasoning but upheld the rejection because at least some of the claims do not require a machine to perform the claimed method and the method recited does not transform an article or matter into another state or thing.
The Fed. Cir. affirmed, stating that the claim fails the “machine-or-transformation test set forth by the Supreme Court and clarified herein.”
On 01/27/09, Bilski filed for writ of certiorari with the following two questions being presented:
This section is a work in progress
Amicus | ps 1) | Arguments in support of Petitioners | For 101? |
---|---|---|---|
AIPLA | ps | “There is no logical connection between the 'machine or transformation' test and whether the claimed process is a law of nature, etc.” | Broad |
Boston IPLA | ps | The machine-or-transformation requirement conflicts with S.Ct. precedent and undermines the broad purpose of section 101, calling the patentability of many landmark inventions into question. | |
Borland Software | ps | “The . . . test is not not well supported by case law” and “is incongruent with . . . Diehr”; “clarification of Diehr . . . is needed”; “. . . policy considerations are important factors that must be considered.” | |
Philips Electronics | ps | “The . . . Court of Appeals' decision raise[s] a host of issues and unanswered questions which will delay new investments in essential research and technologies.” “Broad process claims are commercially necessary. . . .” “The unexpected financial impact of the new mandatory test . . . on patent-centric companies like Philips will be severe.” “The . . . holding inherently discriminates against inventions in the computer, information science, content delivery and information science technologies.” | |
Anne Barschall | ps | “The law with respect to patentable subject matter contains flaws in reasoning that have led to endless litigation and therefore need to be reviewed and corrected.” “Those who seek to reproduce results first developed by others will naturally loudly proclaim that their innovation is stifled by intellectual property law. Their cries are not dissimilar from those of the angry driver, stopped for speeding, who feels entitled to violate the speed limits due to his or her own personal haste. The speed limits, like the patent law, serve a valuable purpose.” | |
Medistem | ps | “If unchecked, Bilski’s test has the potential of creating a disincentive to innovate in the biotechnology industry, and particularly in the area of diagnostic and treatment methods, and the emerging field of 'personalized medicine.'” | Broad |
Accenture-corrected | ps | Broad | |
Franklin Pierce Law Center | ps | ||
John Sutton | ps |
On February 15, 2007, the Fed. Cir. ordered sua sponte, an en banc hearing on ex parte Bilski.
The Fed. Cir. finally handed down its decision in In re Bilski. Stated the court: “The true issue before us then is whether Applicants are seeking to claim a fundamental principle (such as an abstract idea) or a mental process. And the underlying legal question thus presented is what test or set of criteria governs the determination by the Patent and Trademark Office (“PTO”) or courts as to whether a claim to a process is patentable under § 101 or, conversely, is drawn to unpatentable subject matter because it claims only a fundamental principle.”
The Fed. Cir. ruled that, “[b]ecause the applicable test to determine whether a claim is drawn to a patent-eligible process under § 101 is the machine-or-transformation test set forth by the Supreme Court and clarified herein, and Applicants' claim here plainly fails that test, the decision of the Board is AFFIRMED.”
Bilski's impact in various fields:
On May 8, 2008, the Fed. Cir. heard oral arguments.
AUDIO RECORDINGS OF ORAL ARGUMENTS | |||
---|---|---|---|
Part | Link to CAFC File (128 kbps stereo mp3) |
Cached copy, reduced file size (32 kbps, mono mp3) |
Bitsaver (BS) - 30% faster* (32 kbps, mono mp3) |
Original arguments, Oct. 1, 2007 | 56MB, 61 min | BS: | |
Oral Hearing En Banc part 1, May 8, 2008 | 69MB,73 min | BS: | |
Oral Hearing En Banc part 2, May 8, 2008 | 6MB, 7 min | BS: |